Caitong International Asset Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
BIP
Caitong International Asset Management's TAK Position: Q2 2026 in Review
Caitong International Asset Management opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 6,656 shares worth $107K. The stake represents 0.01% of the portfolio and ranks #543 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in TAK as recently as Q4 2025.
Caitong International Asset Management first reported a position in TAK in Q1 2025 and has held it in 4 quarters since. The position peaked at $125K in Q1 2025. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.
- Caitong International Asset Management held 6,656 shares of Takeda Pharmaceutical worth $107K as of Q2 2026.
- Takeda Pharmaceutical was a new Caitong International Asset Management position in Q2 2026.
- Takeda Pharmaceutical made up 0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #543 holding.
- Caitong International Asset Management first reported a position in Takeda Pharmaceutical in Q1 2025 and has held it in 4 quarters since.
- Caitong International Asset Management's Takeda Pharmaceutical position peaked at $125K in Q1 2025.
- 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.
Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.